KOPS - The Institutional Repository of the University of Konstanz

A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine

A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine

Cite This

Files in this item

Checksum: MD5:02300b39e8485d10f43437c2248c3616

PLUMMER, Simon, Stephanie WALLACE, Graeme BALL, Roslyn LLOYD, Paula SCHIAPPARELLI, Alfredo QUIÑONES-HINOJOSA, Thomas HARTUNG, David PAMIES, 2019. A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine. In: Scientific Reports. 9(1), 1407. eISSN 2045-2322. Available under: doi: 10.1038/s41598-018-38130-0

@article{Plummer2019-02-05Human-45642, title={A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine}, year={2019}, doi={10.1038/s41598-018-38130-0}, number={1}, volume={9}, journal={Scientific Reports}, author={Plummer, Simon and Wallace, Stephanie and Ball, Graeme and Lloyd, Roslyn and Schiapparelli, Paula and Quiñones-Hinojosa, Alfredo and Hartung, Thomas and Pamies, David}, note={Article Number: 1407} }

Wallace, Stephanie Pamies, David Schiapparelli, Paula Pamies, David A high throughput histology (microTMA) platform was applied for testing drugs against tumors in a novel 3D heterotypic glioblastoma brain sphere (gBS) model consisting of glioblastoma tumor cells, iPSC-derived neurons, glial cells and astrocytes grown in a spheroid. The differential responses of gBS tumors and normal neuronal cells to sustained treatments with anti-cancer drugs temozolomide (TMZ) and doxorubicin (DOX) were investigated. gBS were exposed to TMZ or DOX over a 7-day period. Untreated gBS tumors increased in size over a 4-week culture period, however, there was no increase in the number of normal neuronal cells. TMZ (100 uM) and DOX (0.3 uM) treatments caused ~30% (P~0.07) and ~80% (P < 0.001) decreases in the size of the tumors, respectively. Neither treatment altered the number of normal neuronal cells in the model. The anti-tumor effects of TMZ and DOX were mediated in part by selective induction of apoptosis. This platform provides a novel approach for screening new anti-glioblastoma agents and evaluating different treatment options for a given patient. A Human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine Quiñones-Hinojosa, Alfredo Plummer, Simon Lloyd, Roslyn Hartung, Thomas Hartung, Thomas Plummer, Simon terms-of-use Quiñones-Hinojosa, Alfredo 2019-04-15T14:10:00Z Lloyd, Roslyn Ball, Graeme Ball, Graeme Schiapparelli, Paula eng 2019-02-05 2019-04-15T14:10:00Z Wallace, Stephanie

Downloads since Apr 15, 2019 (Information about access statistics)

Plummer_2-jeem2dl5qfnv3.pdf 32

This item appears in the following Collection(s)

Search KOPS


Browse

My Account